Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1980 Sep 15;46(6):1401-4.
doi: 10.1002/1097-0142(19800915)46:6<1401::aid-cncr2820460619>3.0.co;2-#.

Fanconi Anemia. Oxymetholone Hepatic Tumors, and Chromosome Aberrations Associated With Leukemic Transition

Case Reports

Fanconi Anemia. Oxymetholone Hepatic Tumors, and Chromosome Aberrations Associated With Leukemic Transition

D A Obeid et al. Cancer. .

Abstract

Jaundice and hepatomegaly developed in a boy with Fanconi anemia after he had undergone treatment with oxymetholone for nine years. A liver scan showed patchy uptake consistent with the presence of space-occupying lesions. After oxymetholone treatment was stopped, the jaundice resolved, the liver size decreased, and the filling defects were no longer detectable on the liver scan. A year later, 5% of his white blood cells showed a consistent chromosomal abnormality. His leukocyte count increased and 85% of these cells showed the same chromosomal abnormality. The rapid replication of this abnormal clone suggests that it was leukemic. The significance of oxymetholone therapy and the occurrence of hepatic tumors and leukemia is discussed.

Similar articles

See all similar articles

Cited by 2 articles

Publication types

Feedback